Stocks
Atossa Therapeutics, Inc.ATOS
NASDAQHealthcareBiotechnology$5.01-0.79%
A clinical-stage biopharmaceutical company developing therapies for breast cancer, with its lead programs focused on the drug candidate endoxifen for treatment and prevention settings. The firm operates without commercialized products and relies on clinical trial progress and regulatory milestones t...
Market Cap: $43.1M52W Range: $3.76 – $19.35
Congressional Interest in Atossa Therapeutics, Inc. (ATOS)
2 members of Congress have disclosed 2 trades in Atossa Therapeutics, Inc. (ATOS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
1
Sells
1
Who in Congress Is Trading ATOS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-25 | Roger W. Marshall | buy | $1K – $15K |
| 2014-11-25 | MIKE KELLY | sell | $1K – $15K |